| abstract |
The present invention relates to tumor-targeting erythrocyte membrane-derived nanoparticles, uses thereof, and methods for producing the same, and specifically, nanoparticles derived from erythrocytes membranes in which quantum dots are captured, therapeutic agents are encapsulated, and tumor-targeting antibodies are attached to the surface. is a Theranostics system that has excellent biocompatibility compared to existing drug delivery systems, excellent immune cell avoidance compared to liposomes, and improved tumor targeting ability, etc., which can be used for molecular imaging diagnosis and anticancer treatment at the same time can be usefully used. |